Marketing-authorisation holder
Syri Pharma Limited
7 medicines in 1 country, as authorisation holder and manufacturer.
Medicines
Every medicine in the registers under its name, current ones first.
7 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Bisoprolol Syri Pharma 0,5 mg/ml, drankDrank | Bisoprolol | Netherlands | Authorised | 2024 |
| Diazepam Syri Pharma 0,4 mg/ml, suspensie voor oraal gebruikSuspensie voor oraal gebruik | Diazepam | Netherlands | Authorised | 2025 |
| Doxazosine Syri Pharma 0,4 mg/ml, suspensie voor oraal gebruikSuspensie voor oraal gebruik | Doxazosin | Netherlands | Authorised | 2025 |
| Lamotrigine Syri Pharma 10 mg/ml, suspensie voor oraal gebruikSuspensie voor oraal gebruik | Lamotrigine | Netherlands | Authorised | 2025 |
| Miprosed 5mg/ml drankDrank | Midazolam | Netherlands | Authorised | 2020 |
| Rosuvastatine Syri Pharma 10 mg/5 ml, drankDrank | Rosuvastatin | Netherlands | Authorised | 2025 |
| Tolterodinetartraat Syri Pharma 0,4 mg/ml, suspensie voor oraal gebruikSuspensie voor oraal gebruik | Tolterodine | Netherlands | Authorised | 2025 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Netherlands | 7 | 7 | 0 | CompaniesAll medicines |
Also in the registers of United Kingdom
Therapeutic areas
The ATC groups most of its medicines belong to, largest first.
- AntihypertensivesCardiovascular system · ATC C02C
- Beta-blocking agentsCardiovascular system · ATC C07A
- Lipid-modifying agentsCardiovascular system · ATC C10A
- UrologicalsGenito-urinary system and sex hormones · ATC G04B
- AntiepilepticsNervous system · ATC N03A
Top substances
The active substances in most of its medicines.
Names in the registers
How the registers spell it, normalised: legal forms, accents and capitals removed.
- syri
- syri limited
Sources and licences
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; October 2026 register, published 7 October 2026; https://assets.publishing.service.gov.uk/media/6ac660fdec9d3aba1e0139d9/MS_Register_-_October_2026.csv; acquired 2026-10-13T22:59:02.704630+00:00; CSV-to-role/site projection is an adaptation under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; Crown copyright MHRA factual register
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
At a glance
- Type
- Marketing-authorisation holder
- Medicines
- 7
- Countries
- 1
- Roles
- Authorisation holder and manufacturer